Topic:Placebo
The placebo effect in horses refers to the phenomenon where a horse experiences a perceived or actual improvement in condition following a treatment that has no therapeutic effect. This effect is often observed in clinical trials and studies where control groups receive a placebo treatment to assess the efficacy of a new drug or therapy. Understanding the placebo effect in horses is important for designing rigorous equine research studies, as it helps distinguish between the actual effects of a treatment and psychological or physiological responses that are not directly caused by the treatment itself. This page compiles peer-reviewed research studies and scholarly articles that explore the mechanisms, implications, and methodologies for accounting for the placebo effect in equine research.
Effects of furosemide on cardiovascular function and performance when given prior to simulated races: a double-blind study. In a double-blind study under simulated racing conditions, six Standardbred horses, which had been trained for 12 weeks, were given 1 mg of furosemide/kg of body weight or saline solution IV 15 minutes before the first of two warm-up workouts (1.6 km at 60-minute intervals). Sixty minutes later, 135 minutes after drug or placebo injection, these horses were driven 1.6 km at maximum speed. Heart rate, respiratory rate, cardiac output, pulmonary trunk pressure, body temperature, PCV, arterial oxygen, and plasma lactic acid were recorded during and after the first warm-up workout and after a simu...
Orgotein in equine navicular disease: a double blind study. Fourteen horses (7 treated with orgotein and 7 treated with a placebo) with navicular disease were studied on a double blind basis. All 14 horses had clinical and radiographic evidence of navicular disease. Orgotein and the placebo were administered by juxtabursal injection. Of the 7 orgotein-treated horses, 3 responded but none of the 7 placebo-treated horses responded. The difference was statistically significant (P less than 0.05).
Immunization of man and animals against influenza by oral and intranasal routes. Live human and equine influenza virus strains modified by serial passage on allantois-on-shell system (AOS) in the presence of normal horse serum were administered orally or intranasally to volunteers or horses. Mostly mild clinical short-lasting reactions, replication in nasal mucosae, transmission to placebo recipients and significant local or circulating antibody rises were observed following administration to volunteers of strains modified by five or less serial passages on AOS in the presence of normal horse serum (NHS). Milder clinical reactions, no replication, no viral transmission and...
Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses. Degenerative joint disease is one of the main causes of equine early retirement from pleasure riding or a performance career. The disease is initially triggered by an abnormal loading of normal cartilage or a normal loading of abnormal cartilage. This primary insult is accompanied with joint inflammation, which leads to further progressive degeneration of the articular cartilage and changes in the surrounding tissues. Therefore, in search for an effective treatment, 75 adult horses with early signs of degenerative fetlock joint disease were enrolled in a randomized, multicenter, double-blinded...